1/23
Vocabulary flashcards covering adrenergic agonists, antagonists, biosynthesis, metabolism, and SAR from PHAR 441 lecture notes.
Sympathomimetics
Agonists and substances that produce physiological effects similar to the stimulation of sympathetic nervous activity.
Sympatholytics
Antagonists and substances that decrease or block sympathetic nervous activity.
Mydriasis
The dilation of the pupil of the eye stimulated by sympathetic nerve impulses.
Tyrosine Hydroxylase
The enzyme that converts L-Tyrosine to L-Dihydroxyphenylalanine (L-Dopa) in catecholamine biosynthesis.
L-Aromatic Amino Acid Decarboxylase
The enzyme that converts L-Dopa to Dopamine (DA) in catecholamine biosynthesis.
Dopamine β-Hydroxylase
The enzyme that converts Dopamine to Norepinephrine (NE) in catecholamine biosynthesis.
Phenylethanolamine N-methyltransferase
The enzyme that converts Norepinephrine to Epinephrine using S-Adenosyl methionine (SAM) as a methyl donor.
Monoamine Oxidase
A mitochondrial enzyme that oxidizes primary (−NH2) or secondary (−NHR) amines into aldehyde (−CHO) functional groups.
Catechol-O-methyltransferase
An enzyme that adds a methyl group to the 3′-OH position of a catechol ring.
Vanillylmandelic Acid
A major end product of norepinephrine and epinephrine metabolism that is excreted in urine.
Pheochromocytoma
An adrenal gland tumor that secretes catecholamines, resulting in elevated levels of urinary Vanillylmandelic Acid (VMA).
Adrenergic Phenylethylamine Core Structure
The essential structural features required for adrenergic agonist activity, consisting of a β-phenylethylamine backbone, a catechol ring, and a (1R)-OH group.
Colterol
An N-t-butyl substituted selective β2 agonist that demonstrates low inactivation by monoamine oxidase (MAO).
Adrenochrome
A oxidation product formed from epinephrine via a quinone analog intermediate.
Phenylephrine
A selective α1 agonist and OTC nasal decongestant lacking a 4′-OH group, which prevents degradation by COMT and extends duration of action.
Metaproterenol
A selective β2 agonist with a 3′,5′-diOH (resorcinol) ring structure, making it resistant to COMT metabolism and granting improved oral absorption.
Dipivefrin
A diester prodrug of epinephrine formed with pivalic acid that increases lipophilicity and eye penetration while decreasing ocular irritation during glaucoma treatment.
Imidazolines
A structural class of selective α1 agonists, such as naphazoline, tetrahydrozoline, and oxymetazoline, that are resistant to degradation by MAO and COMT.
Guanidines
A structural class of selective α2 agonists, including clonidine, guanabenz, and guanfacine, that stimulate central α2 receptors to produce an antihypertensive effect.
Levalbuterol
The active (R)-enantiomer of albuterol, which functions as a short-acting β2 agonist with a duration of action of 3–6hours.
Selective α1A-Blockers
Antagonists such as tamsulosin (FLOMAX) and alfuzosin (UROXATRAL) that selectively target α1A receptors abundant in the prostate to treat benign prostatic hyperplasia (BPH).
Aryloxypropanolamines
The chemical backbone class characteristic of β-blockers, defined by an Aryl-O-CH2-CH(OH)-CH2-NH-R structure.
Propranolol
A nonselective β-blocker with high lipophilicity (log(P)=3.1) widely used as an antihypertensive drug.
Atenolol
A selective β1-blocker with low lipophilicity (log(P)=0.1) that produces fewer central nervous system side effects than propranolol.